
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GSK-3 in liver diseases: Friend or foe?
Maria Rita Emma, Giuseppa Augello, Antonella Cusimano, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 9, pp. 118743-118743
Open Access | Times Cited: 17
Maria Rita Emma, Giuseppa Augello, Antonella Cusimano, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 9, pp. 118743-118743
Open Access | Times Cited: 17
Showing 17 citing articles:
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 6
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites (2024) Vol. 14, Iss. 4, pp. 218-218
Open Access | Times Cited: 6
Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications
Zixin Liang, Shanshan Li, Zhiyu Wang, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Zixin Liang, Shanshan Li, Zhiyu Wang, et al.
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access
Mechanistic evaluation of Jiu Wei Qing Zhi Gao in non-alcoholic fatty liver disease: insights from network Pharmacology and experimental validation
Qinlei Chen, Qianfeng Hu, Fan Zhang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Qinlei Chen, Qianfeng Hu, Fan Zhang, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Network-level analysis of ageing and its relationship with diseases and tissue regeneration in the mouse liver
Manisri Porukala, P. K. Vinod
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Manisri Porukala, P. K. Vinod
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
GSK3-Driven Modulation of Inflammation and Tissue Integrity in the Animal Model
Friederike Kühl, Korbinian Brand, Ralf Lichtinghagen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8263-8263
Open Access | Times Cited: 4
Friederike Kühl, Korbinian Brand, Ralf Lichtinghagen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8263-8263
Open Access | Times Cited: 4
New insights into the role of GSK-3β in the brain: from neurodegenerative disease to tumorigenesis
Shenjin Lai, Peng Wang, Jingru Gong, et al.
PeerJ (2023) Vol. 11, pp. e16635-e16635
Open Access | Times Cited: 10
Shenjin Lai, Peng Wang, Jingru Gong, et al.
PeerJ (2023) Vol. 11, pp. e16635-e16635
Open Access | Times Cited: 10
Hyperatins A–D, highly oxidized polycyclic polyprenylated acylphloroglucinols from Hypericum perforatum L. with hypoglycemic potential in liver cells
Yi Guo, Qianqian Xu, Bo Tao, et al.
Phytochemistry (2024) Vol. 221, pp. 114047-114047
Closed Access | Times Cited: 3
Yi Guo, Qianqian Xu, Bo Tao, et al.
Phytochemistry (2024) Vol. 221, pp. 114047-114047
Closed Access | Times Cited: 3
Evaluation of the effect of GSK-3β on liver cancer based on the PI3K/AKT pathway
Jiageng Guo, Xinya Jiang, Jing Lian, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Jiageng Guo, Xinya Jiang, Jing Lian, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Schisandrin A alleviates non-alcoholic fatty liver disease by improving liver metabolic disorders and suppressing the GSK3β signaling pathway
Zong Li, Rui Xu, Yunxia Sun, et al.
Food Bioscience (2024), pp. 105245-105245
Closed Access | Times Cited: 2
Zong Li, Rui Xu, Yunxia Sun, et al.
Food Bioscience (2024), pp. 105245-105245
Closed Access | Times Cited: 2
Mechanisms of Gynostemma pentaphyllum against non‐alcoholic fibre liver disease based on network pharmacology and molecular docking
Cunzhi Wang, Pengrui Wang, Wenbin Chen, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 13, pp. 3760-3771
Open Access | Times Cited: 11
Cunzhi Wang, Pengrui Wang, Wenbin Chen, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 13, pp. 3760-3771
Open Access | Times Cited: 11
Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice
Hui Huang, Jie Xue, Mei-Lin Xie, et al.
Strahlentherapie und Onkologie (2023) Vol. 200, Iss. 5, pp. 444-452
Closed Access | Times Cited: 4
Hui Huang, Jie Xue, Mei-Lin Xie, et al.
Strahlentherapie und Onkologie (2023) Vol. 200, Iss. 5, pp. 444-452
Closed Access | Times Cited: 4
Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis
Peng Lyu, Fengyue Li, Runzhi Deng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167233-167233
Closed Access | Times Cited: 1
Peng Lyu, Fengyue Li, Runzhi Deng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 6, pp. 167233-167233
Closed Access | Times Cited: 1
Hepatic-Metabolic Activity of α-Lipoic Acid—Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease
Klaudia Sztolsztener, Adrian Chabowski
Nutrients (2024) Vol. 16, Iss. 10, pp. 1501-1501
Open Access | Times Cited: 1
Klaudia Sztolsztener, Adrian Chabowski
Nutrients (2024) Vol. 16, Iss. 10, pp. 1501-1501
Open Access | Times Cited: 1
Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death
Danmei Zhang, Chunxia Shi, Qingqi Zhang, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Danmei Zhang, Chunxia Shi, Qingqi Zhang, et al.
Journal of Inflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis
Chia‐Ling Chen, Po‐Chun Tseng, Rahmat Dani Satria, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4669-4669
Open Access | Times Cited: 3
Chia‐Ling Chen, Po‐Chun Tseng, Rahmat Dani Satria, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4669-4669
Open Access | Times Cited: 3
GSK3β/NF-κB -dependent transcriptional regulation of homeostatic hepatocyte Tnf production
Maya R. Grayck, William C. McCarthy, Mack Solar, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 4, pp. G374-G384
Closed Access
Maya R. Grayck, William C. McCarthy, Mack Solar, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 4, pp. G374-G384
Closed Access
Royal jelly arranges apoptotic and oxidative stress pathways and reduces damage to liver tissues of rats by down-regulation of Bcl-2, GSK3 and NF-κB and up-regulation of caspase and Nrf-2 protein signalling pathways
Abdullah Nabi Aslan, Özlem Gök, Seda Beyaz, et al.
Biomarkers (2022) Vol. 28, Iss. 2, pp. 217-226
Closed Access | Times Cited: 2
Abdullah Nabi Aslan, Özlem Gök, Seda Beyaz, et al.
Biomarkers (2022) Vol. 28, Iss. 2, pp. 217-226
Closed Access | Times Cited: 2
Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death
Danmei Zhang, Chunxia Shi, Qingqi Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Danmei Zhang, Chunxia Shi, Qingqi Zhang, et al.
Research Square (Research Square) (2023)
Open Access